Electromed price target raised to $36 from $33 at Lake Street

Lake Street analyst Brooks O’Neil raised the firm’s price target on Electromed (ELMD) to $36 from $33 and keeps a Buy rating on the shares, noting that the company posted “record” Q2 results. While noting that the stock has appreciated about 132% in the past year, the firm believes there is “still room for upside given continued strong growth and solid execution from management,” the analyst tells investors.